| The genomic landscape of endocrine-resistant advanced breast cancers P Razavi, MT Chang, G Xu, C Bandlamudi, DS Ross, N Vasan, Y Cai, ... Cancer cell 34 (3), 427-438. e6, 2018 | 804 | 2018 |
| Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, ... Journal of clinical oncology 37 (4), 286, 2019 | 503 | 2019 |
| Genome doubling shapes the evolution and prognosis of advanced cancers CM Bielski, A Zehir, AV Penson, MTA Donoghue, W Chatila, J Armenia, ... Nature genetics 50 (8), 1189-1195, 2018 | 490 | 2018 |
| Tumour lineage shapes BRCA-mediated phenotypes P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, ... Nature 571 (7766), 576-579, 2019 | 341 | 2019 |
| COVID-19 in patients with lung cancer J Luo, H Rizvi, IR Preeshagul, JV Egger, D Hoyos, C Bandlamudi, ... Annals of Oncology 31 (10), 1386-1396, 2020 | 295 | 2020 |
| Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas AJ Schoenfeld, H Rizvi, C Bandlamudi, JL Sauter, WD Travis, ... Annals of Oncology 31 (5), 599-608, 2020 | 229 | 2020 |
| CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia ME McNerney, CD Brown, X Wang, ET Bartom, S Karmakar, ... Blood, The Journal of the American Society of Hematology 121 (6), 975-983, 2013 | 176 | 2013 |
| Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group D Mandelker, M Donoghue, S Talukdar, C Bandlamudi, P Srinivasan, ... Annals of Oncology 30 (8), 1221-1231, 2019 | 168 | 2019 |
| The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung Cancer AJ Schoenfeld, C Bandlamudi, JA Lavery, J Montecalvo, A Namakydoust, ... Clinical Cancer Research 26 (21), 5701-5708, 2020 | 161 | 2020 |
| Clinical utility of prospective molecular characterization in advanced endometrial cancer TE Soumerai, MTA Donoghue, C Bandlamudi, P Srinivasan, MT Chang, ... Clinical Cancer Research 24 (23), 5939-5947, 2018 | 123 | 2018 |
| Ordered and deterministic cancer genome evolution after p53 loss T Baslan, JP Morris IV, Z Zhao, J Reyes, YJ Ho, KM Tsanov, J Bermeo, ... Nature 608 (7924), 795-802, 2022 | 116 | 2022 |
| Bionimbus: a cloud for managing, analyzing and sharing large genomics datasets AP Heath, M Greenway, R Powell, J Spring, R Suarez, D Hanley, ... Journal of the American Medical Informatics Association 21 (6), 969-975, 2014 | 99 | 2014 |
| A comprehensive comparison of early-onset and average-onset colorectal cancers A Cercek, WK Chatila, R Yaeger, H Walch, GDS Fernandes, A Krishnan, ... JNCI: Journal of the National Cancer Institute 113 (12), 1683-1692, 2021 | 95 | 2021 |
| Cancer susceptibility mutations in patients with urothelial malignancies MI Carlo, V Ravichandran, P Srinavasan, C Bandlamudi, Y Kemel, ... Journal of Clinical Oncology 38 (5), 406, 2020 | 78 | 2020 |
| Genomic landscape of uterine sarcomas defined through prospective clinical sequencing ML Hensley, SS Chavan, DB Solit, R Murali, R Soslow, S Chiang, ... Clinical Cancer Research 26 (14), 3881-3888, 2020 | 74 | 2020 |
| Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression TP Stricker, CD Brown, C Bandlamudi, M McNerney, R Kittler, V Montoya, ... PLoS genetics 13 (3), e1006589, 2017 | 67 | 2017 |
| Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA SS Chandran, J Ma, MG Klatt, F Dündar, C Bandlamudi, P Razavi, ... Nature medicine 28 (5), 946-957, 2022 | 62 | 2022 |
| The context-specific role of germline pathogenicity in tumorigenesis P Srinivasan, C Bandlamudi, P Jonsson, Y Kemel, SS Chavan, ... Nature genetics 53 (11), 1577-1585, 2021 | 59 | 2021 |
| Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes W Wong, MA Lowery, MF Berger, Y Kemel, B Taylor, A Zehir, P Srinivasan, ... Cancer 125 (9), 1441-1448, 2019 | 39 | 2019 |
| Phase and context shape the function of composite oncogenic mutations AN Gorelick, FJ Sánchez-Rivera, Y Cai, CM Bielski, E Biederstedt, ... Nature 582 (7810), 100-103, 2020 | 38 | 2020 |
